ALSO NOTED: Zentiva under pressure; New China drug manufacturing pact; Par ships new generic;

> Being sued by Teva over patent rights was bad enough, but Czech drug maker Zentiva is also facing court challenges over a land sale and, separately, debt collection. Meanwhile, its first-half profits are down almost 7 percent from last year because of "pricing pressure." Report

> A British pharmacy chain has inked a deal to manufacture its own prescription drugs. The Co-operative Group's meds will be made in China via a joint venture with Tasly Group, one of that country's largest makers of herbal remedies. Report 

> Par Pharmaceutical has started shipping new 100 mg and 200 mg strengths of its generic form of TOPROL-XL, AstraZeneca's beta-1-selective adrenoceptor blocking agent. Release

And Finally... Say goodbye to the last remaining shred of the Soviet Union's pharmaceuticals industry (such as it was). Its sole remaining drug, ethmozine, a treatment for arrythmia, will no longer be sold. Until now, it's been made by Shire---and it does still work. It's just not much in demand. All together now: Do svidaniya! Report (WSJ sub. req.)